In Data - Pharma Technology Focus | Issue 123

Go to article: Home | The promise of billion-dollar KRAS drugs

Go to article: In this issue

Go to article: Contents

Go to article: Wek-tec Company Insight

Go to article: CSafe Global

Go to article: Briefing

Go to article: Industry news

Go to article: The pharma industry briefing

Go to article: SHL Medical Company Insight

Go to article: SHL Medical

Go to article: Agilent

Go to article: Comment

Go to article: The potential of virtual reality-based therapy for serious mental disorders

Go to article: Brazil: an untapped market for big pharma manufacturing

Go to article: More big wins for the AstraZeneca-Daiichi Sankyo collaboration

Go to article: Dry powder inhalers carry potential to decrease greenhouse emissions

Go to article: Black participants severely underrepresented in global oncology studies

Go to article: Polio outbreak in New York state due to low vaccination coverage

Go to article: Mimotopes Company Insight

Go to article: Mimotopes

Go to article: Skyepharma

Go to article: In Depth

Go to article: Exploring the promise of billion-dollar KRAS drugs

Go to article: Nanorobots: small solutions to big delivery problems

Go to article: Foreign investments amplify the nucleic acid therapeutics field

Go to article: Going beyond the mirage of complete skin clearance in psoriasis

Go to article: As Russia’s clinical trials sector falls, Ukraine rebuilds

Go to article: CMO Moves: Regulatory catalysts for drug manufacturing—September

Go to article: Dr. Paul Lohmann

Go to article: Baxter

Go to article: In Data

Go to article: Top pharma companies best positioned to weather industry disruption

Go to article: Which pharma companies lead the way in artificial intelligence?

Go to article: North America sees a hiring jump in big data roles in pharma

Go to article: Cloud computing mentions decrease in pharma filings

Go to article: Events

Go to article: Next issue

Top pharma companies best positioned to weather industry disruption